Northern Trust Corp Evolus, Inc. Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
A detailed history of Northern Trust Corp transactions in Evolus, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 531,167 shares of EOLS stock, worth $7.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
531,167
Previous 485,783
9.34%
Holding current value
$7.9 Million
Previous $7.87 Million
25.48%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding EOLS
# of Institutions
169Shares Held
48.8MCall Options Held
57.2KPut Options Held
5.5K-
Perceptive Advisors LLC New York, NY5.15MShares$76.6 Million1.9% of portfolio
-
Tang Capital Management LLC San Diego, CA5MShares$74.4 Million4.14% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$59.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.17MShares$47.2 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.13MShares$46.6 Million1.74% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $835M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...